Healthcare Regulatory & Qui Tam Defense Insurance in Maryland

Maryland at a glance

State false claims statute

Maryland False Health Claims Act

A healthcare-specific qui tam statute, narrower in scope than an all-program false claims act.

Rate-setting authority

Health Services Cost Review Commission

Maryland is the only state with all-payer hospital rate-setting under a federal waiver.

Fraud enforcement office

Attorney General's Medicaid Fraud Control Unit

Decides intervention in qui tam suits and pursues criminal Medicaid fraud referrals.

Insurance regulator

Maryland Insurance Administration

Confirm current licensing and filing guidance directly with the administration.

All-payer rate-setting is a Maryland-only regulatory layer

Maryland's Health Services Cost Review Commission sets hospital rates that apply uniformly across Medicare, Medicaid, and commercial payers under a federal waiver arrangement unique to this state, meaning billing-pattern anomalies at a Maryland hospital are visible against a single rate schedule rather than fragmented across payer-specific rates. This visibility does not itself create liability, but it means Commission rate-compliance data can be a starting point for a Medicaid Fraud Control Unit referral in ways that would not arise the same way in a state without unified rate-setting.

The Maryland False Health Claims Act and its healthcare-specific scope

Unlike a general false claims act, Maryland's statute is written specifically to reach healthcare claims, authorizing qui tam relator suits over Medicaid and other state healthcare program billing, with the Attorney General's Medicaid Fraud Control Unit deciding whether to intervene. Because the statute's scope is narrower than an all-program false claims act, providers should confirm whether a given billing dispute falls within its healthcare-specific reach or would instead proceed under general fraud or false-statement law.

Baltimore-Washington research corridor and federal-health overlap

Maryland's Baltimore-Washington corridor concentration of medical research institutions and federal-health agencies means providers here often interact with both state Medicaid Fraud Control Unit inquiries and federal program-integrity reviews tied to NIH or CMS-adjacent funding, sometimes on the same underlying grant or clinical arrangement. Exclusion-list screening, billing audits, and documented referral-arrangement review remain the baseline controls; civil penalties and knowing misconduct are not insurable regardless of which agency initiates the inquiry.

Confirm current rate-review and MFCU referral practice with counsel

The interaction between Commission rate compliance and Attorney General referral practice evolves; confirm current procedures with counsel before treating a prior Maryland matter as a template.

Who we write this for in Maryland

Healthcare regulatory defense FAQs for Maryland